WFG Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$35K Sell
896
-29
-3% -$1.1K 0.01% 791
2017
Q1
$35K Sell
925
-21
-2% -$818 0.01% 754
2016
Q4
$35K Sell
946
-376
-28% -$13.4K 0.01% 799
2016
Q3
$46K Sell
1,322
-7
-0.5% -$245 0.01% 732
2016
Q2
$43K Sell
1,329
-34
-2% -$1.04K 0.01% 716
2016
Q1
$39K Sell
1,363
-164
-11% -$4.37K 0.01% 728
2015
Q4
$51K Buy
1,527
+290
+23% +$9.02K 0.02% 652
2015
Q3
$35K Sell
1,237
-81
-6% -$2.83K 0.01% 745
2015
Q2
$53K Sell
1,318
-1
-0.1% -$45 0.01% 709
2015
Q1
$65K Sell
1,319
-816
-38% -$37.8K 0.02% 659
2014
Q4
$97K Buy
+2,135
New +$83.9K 0.02% 646

Other funds holding AVNS

WFG Advisors's AVNS Position: Q2 2017 in Review

WFG Advisors reduced its Avanos Medical (AVNS) stake by 3.1% in Q2 2017, selling an estimated $1.1K and leaving 896 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #791.

WFG Advisors first reported a position in AVNS in Q4 2014 and has held it in 11 quarters since. The position peaked at $97K in Q4 2014. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • WFG Advisors held 896 shares of Avanos Medical worth $35K as of Q2 2017.
  • WFG Advisors sold 29 Avanos Medical shares in Q2 2017, an estimated $1.1K.
  • Avanos Medical made up 0.01% of WFG Advisors's portfolio in Q2 2017, its #791 holding.
  • WFG Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 11 quarters since.
  • WFG Advisors's Avanos Medical position peaked at $97K in Q4 2014.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.